ATP promotes cell survival via regulation of cytosolic [Ca2+] and Bcl-2/Bax ratio in lung cancer cells

American Journal of Physiology - Cell Physiology

Volumn 310, Issue 2, 2016, Pages C99-C114

  Song, Shanshan ^a   Jacobson, Krista N ^a   McDermott, Kimberly M ^a   Reddy, Sekhar P ^b   Cress, Anne E ^a   Tang, Haiyang ^a   Dudek, Steven M ^b   Black, Stephen M ^a   Garcia, Joe G N ^a   Makino, Ayako ^a   Yuan, Jason X J ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Bax; Bcl 2; Calcium signaling; Cell apoptosis; Cell proliferation; Purinergic receptor

Indexed keywords

ADENOSINE TRIPHOSPHATE; CALCIUM ION; PROTEIN BAX; PROTEIN BCL 2; PURINERGIC P2X1 RECEPTOR; PURINERGIC P2X2 RECEPTOR; PURINERGIC P2X3 RECEPTOR; PURINERGIC P2X4 RECEPTOR; PURINERGIC P2X5 RECEPTOR; PURINERGIC P2X6 RECEPTOR; PURINERGIC P2X7 RECEPTOR; PURINERGIC P2Y1 RECEPTOR; PURINERGIC P2Y11 RECEPTOR; PURINERGIC P2Y2 RECEPTOR; PURINERGIC P2Y4 RECEPTOR; PURINERGIC P2Y6 RECEPTOR; BAX PROTEIN, HUMAN; BCL2 PROTEIN, HUMAN; CALCIUM;

APOPTOSIS; ARTICLE; CALCIUM CELL LEVEL; CALCIUM CHELATION; CALCIUM SIGNALING; CALCIUM TRANSPORT; CELL LEVEL; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; CELLULAR DISTRIBUTION; CHELATION; CONTROLLED STUDY; CYTOSOL; CYTOTOXICITY; EPITHELIUM CELL; EXTRACELLULAR CALCIUM; HUMAN; HUMAN CELL; LUNG CANCER CELL LINE; PRIORITY JOURNAL; REGULATORY MECHANISM; RESPIRATORY EPITHELIUM; TUMOR GROWTH; TUMOR MICROENVIRONMENT; GENE EXPRESSION REGULATION; LUNG TUMOR; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

ADENOSINE TRIPHOSPHATE; BCL-2-ASSOCIATED X PROTEIN; CALCIUM; CALCIUM SIGNALING; CELL LINE, TUMOR; CELL SURVIVAL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 84954501223     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00092.2015     Document Type: Article

References (47)

1. Berridge MJ, Bootman MD, Roderick HL. Calcium signalling: dynam-ics, homeostasis and remodelling. Nat Rev Mol Cell Biol 4: 517-529, 2003.
2. Burnstock G. The past, present and future of purine nucleotides as signalling molecules. Neuropharmacology 36: 1127-1139, 1997.
3. Burnstock G. Purine and pyrimidine receptors. Cell Mol Life Sci 64: 1471-1483, 2007.
4. Burnstock G, Di Virgilio F. Purinergic signalling and cancer. Purinergic Signal 9: 491-540, 2013.
5. Burnstock G, Knight GE. Cellular distribution and functions of P2 receptor subtypes in different systems. Int Rev Cytol 240: 31-304, 2004.
6. Chahwala SB, Cantley LC. Extracellular ATP induces ion fluxes and inhibits growth of Friend erythroleukemia cells. J Biol Chem 259: 13717-13722, 1984.
7. Chen R, Valencia I, Zhong F, McColl KS, Roderick HL, Bootman MD, Berridge MJ, Conway SJ, Holmes AB, Mignery GA, Velez P, Distelhorst CW. Bcl-2 functionally interacts with inositol 1,4,5-trisphosphate receptors to regulate calcium release from the ER in response to inositol 1,4,5-trisphosphate. J Cell Biol 166: 193-203, 2004.
8. Choi DW. Calcium: still center-stage in hypoxic-ischemic neuronal death. Trends Neurosci 18: 58-60, 1995.
9. Wojcik SE, Aqeilan RI, Zupo S, Dono M, Rassenti L, Alder H, Volinia S, Liu CG, Kipps TJ, Negrini M, Croce CM. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci USA 102: 13944-13949, 2005.
10. Fickova M, Macho L, Brtko J. A comparison of the effects of tributyltin chloride and triphenyltin chloride on cell proliferation, proapoptotic p53, Bax, and antiapoptotic Bcl-2 protein levels in human breast cancer MCF-7 cell line. Toxicol In Vitro 29: 727-731, 2015.
11. Garcia-Guzman M, Soto F, Laube B, Stuhmer W. Molecular cloning and functional expression of a novel rat heart P2X purinoceptor. FEBS Lett 388: 123-127, 1996.
12. Greig AV, Linge C, Healy V, Lim P, Clayton E, Rustin MH, Mc Grouther DA, Burnstock G. Expression of purinergic receptors in non-melanoma skin cancers and their functional roles in A431 cells. J Invest Dermatol 121: 315-327, 2003.
13. Hanson CJ, Bootman MD, Distelhorst CW, Maraldi T, Roderick HL. The cellular concentration of Bcl-2 determines its proor anti-apoptotic effect. Cell Calcium 44: 243-258, 2008.
14. Lewis CJ, Surprenant A, Evans RJ. 2,3-O-(2,4,6-trinitrophenyl) adenosine 5-triphosphate (TNP-ATP)-a nanomolar affinity antagonist at rat mesenteric artery P2X receptor ion channels. Br J Pharmacol 124: 1463-1466, 1998.
15. Majors BS, Betenbaugh MJ, Chiang GG. Links between metabolism and apoptosis in mammalian cells: applications for anti-apoptosis engineering. Metab Eng 9: 317-326, 2007.
16. McLaren GJ, Lambrecht G, Mutschler E, Baumert HG, Sneddon P, Kennedy C. Investigation of the actions of PPADS, a novel P2x-purinoceptor antagonist, in the guinea-pig isolated vas deferens. Br J Pharmacol 111: 913-917, 1994.
17. Meleady P, Clynes M. Bromodeoxyuridine increases keratin 19 protein expression at a posttranscriptional level in two human lung tumor cell lines. In Vitro Cell Dev Biol Anim 37: 536-542, 2001.
18. Miao LJ, Huang SF, Sun ZT, Gao ZY, Zhang RX, Liu Y, Wang J. MiR-449c targets c-Myc and inhibits NSCLC cell progression. FEBS Lett 587: 1359-1365, 2013.
19. Michaelis M, Nieswandt B, Stegner D, Eilers J, Kraft R. STIM1, STIM2, and Orai1 regulate store-operated calcium entry and purinergic activation of microglia. Glia 63: 652-663, 2015.
20. Mistafa O, Hogberg J, Stenius U. Statins and ATP regulate nuclear pAkt via the P2X7 purinergic receptor in epithelial cells. Biochem Biophys Res Commun 365: 131-136, 2008.
21. Mistafa O, Stenius U. Statins inhibit Akt/PKB signaling via P2X7 receptor in pancreatic cancer cells. Biochem Pharmacol 78: 1115-1126, 2009.
22. Monteith GR, McAndrew D, Faddy HM, Roberts-Thomson SJ. Calcium and cancer: targeting Ca2 transport. Nat Rev Cancer 7: 519-530, 2007.
23. Nichols CM, Povstyan OV, Albert AP, Gordienko DV, Khan O, Vasilikostas G, Khong TK, Wan A, Reddy M, Harhun MI. Vascular smooth muscle cells from small human omental arteries express P2X1 and P2X4 receptor subunits. Purinergic Signal 10: 565-572, 2014.
24. Nicotera P, Orrenius S. The role of calcium in apoptosis. Cell Calcium 23: 173-180, 1998.
25. Oakes SA, Scorrano L, Opferman JT, Bassik MC, Nishino M, Pozzan T, Korsmeyer SJ. Proapoptotic BAX and BAK regulate the type 1 inositol trisphosphate receptor and calcium leak from the endoplasmic reticulum. Proc Natl Acad Sci USA 102: 105-110, 2005.
26. Pellegatti P, Raffaghello L, Bianchi G, Piccardi F, Pistoia V, Di Virgilio F. Increased level of extracellular ATP at tumor sites: in vivo imaging with plasma membrane luciferase. PLoS One 3: e2599, 2008.
27. Pinton P, Ferrari D, Rapizzi E, Di Virgilio F, Pozzan T, Rizzuto R. The Ca2 concentration of the endoplasmic reticulum is a key determinant of ceramide-induced apoptosis: significance for the molecular mechanism of Bcl-2 action. EMBO J 20: 2690-2701, 2001.
28. Pinton P, Ferrari D, Rapizzi E, Di Virgilio F, Pozzan T, Rizzuto R. A role for calcium in Bcl-2 action? Biochimie 84: 195-201, 2002.
29. Pizzo P, Murgia M, Zambon A, Zanovello P, Bronte V, Pietrobon D, Di Virgilio F. Role of P2z purinergic receptors in ATP-mediated killing of tumor necrosis factor (TNF)-sensitive and TNF-resistant L929 fibroblasts. J Immunol 149: 3372-3378, 1992.
30. Prevarskaya N, Skryma R, Shuba Y. Ion channels and the hallmarks of cancer. Trends Mol Med 16: 107-121, 2010.
31. Ralevic V, Burnstock G. Receptors for purines and pyrimidines. Pharmacol Rev 50: 413-492, 1998.
32. Schaafsma HE, Ramaekers FC. Cytokeratin subtyping in normal and neoplastic epithelium: basic principles and diagnostic applications. Pathol Annu 29: 21-62, 1994.
33. Schafer R, Sedehizade F, Welte T, Reiser G. ATP- and UTP activated P2Y receptors differently regulate proliferation of human lung epithelial tumor cells. Am J Physiol Lung Cell Mol Physiol 285: L376-L385, 2003.
34. Schultze-Mosgau A, Katzur AC, Arora KK, Stojilkovic SS, Diedrich K, Ortmann O. Characterization of calcium-mobilizing, purinergic P2Y(2) receptors in human ovarian cancer cells. Mol Hum Reprod 6: 435-442, 2000.
35. Scodelaro Bilbao P, Boland R, Russo de Boland A, Santillan G. ATP modulation of mitogen activated protein kinases and intracellular Ca2 in breast cancer (MCF-7) cells. Arch Biochem Biophys 466: 15-23, 2007.
36. Shen JB, Cronin C, Sonin D, Joshi BV, Gongora Nieto M, Harrison D, Jacobson KA, Liang BT. P2X purinergic receptor-mediated ionic current in cardiac myocytes of calsequestrin model of cardiomyopathy: implications for the treatment of heart failure. Am J Physiol Heart Circ Physiol 292: H1077-H1084, 2007.
37. Soliman EM, Rodrigues MA, Gomes DA, Sheung N, Yu J, Amaya MJ, Nathanson MH, Dranoff JA. Intracellular calcium signals regulate growth of hepatic stellate cells via specific effects on cell cycle progression. Cell Calcium 5: 284-292, 2009.
38. Song MY, Makino A, Yuan JX. STIM2 contributes to enhanced store operated Ca2 entry in pulmonary artery smooth muscle cells from patients with idiopathic pulmonary arterial hypertension. Pulm Circ 1: 84-94, 2011.
39. Takai E, Tsukimoto M, Harada H, Sawada K, Moriyama Y, Kojima S. Autocrine regulation of TGF-beta1-induced cell migration by exocytosis of ATP and activation of P2 receptors in human lung cancer cells. J Cell Sci 125: 5051-5060, 2012.
40. Vanden Abeele F, Skryma R, Shuba Y, Van Coppenolle F, Slomianny C, Roudbaraki M, Mauroy B, Wuytack F, Prevarskaya N. Bcl-2-dependent modulation of Ca2 homeostasis and store-operated channels in prostate cancer cells. Cancer Cell 1: 169-179, 2002.
41. Vander Heiden MG, Thompson CB. Bcl-2 proteins: regulators of apoptosis or of mitochondrial homeostasis? Nat Cell Biol 1: E209-E216, 1999.
42. Vanoverberghe K, Mariot P, Vanden Abeele F, Delcourt P, Parys JB, Prevarskaya N. Mechanisms of ATP-induced calcium signaling and growth arrest in human prostate cancer cells. Cell Calcium 34: 75-85, 2003.
43. Wang Q, Wang L, Feng YH, Li X, Zeng R, Gorodeski GI. P2X7 receptor-mediated apoptosis of human cervical epithelial cells. Am J Physiol Cell Physiol 287: C1349-C1358, 2004.
44. White N, Burnstock G. P2 receptors and cancer. Trends Pharmacol Sci 27: 211-217, 2006.
45. Wu DW, Wu TC, Wu JY, Cheng YW, Chen YC, Lee MC, Chen CY, Lee H. Phosphorylation of paxillin confers cisplatin resistance in non-small cell lung cancer via activating ERK-mediated Bcl-2 expression. Oncogene 33: 4385-4395, 2014.
46. Yamamura A, Yamamura H, Zeifman A, Yuan JX. Activity of Ca2-activated Cl channels contributes to regulating receptor- and store operated Ca2 entry in human pulmonary artery smooth muscle cells. Pulm Circ 1: 269-279, 2011.
47. Zundelevich A, Elad-Sfadia G, Haklai R, Kloog Y. Suppression of lung cancer tumor growth in a nude mouse model by the Ras inhibitor salirasib (farnesylthiosalicylic acid). Mol Cancer Ther 6: 1765-1773, 2007.